User:Mr. Ibrahem/Tecovirimat

Tecovirimat, sold under the brand name Tpoxx, is an antiviral medication with activity against smallpox. Other uses may include monkeypox, cowpox, and complications of smallpox vaccination. It is taken by mouth.

Common side effects include nausea, headache, and abdominal pain. No serious side effects have been seen. It works by blocking orthopoxvirus VP37 protein, which prevents the virus from leave a cell.

Tecovirimat became the first drug approved for use in smallpox in the United States in 2018. Two million doses are in the US Strategic National Stockpile in the event that smallpox reoccurs. As of 2021 it is not approved in Europe.